<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) or 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Cell Pathways Holdings, Inc.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 23-2969600
- ------------------------------------------------------- ------------------
(State of Incorporation or Organization) (I.R.S. Employer
Identification No.)
702 Electronic Drive, Horsham, Pennsylvania 19044
- ------------------------------------------------------- ------------------
(Address of Principal Executive Offices) (Zip Code)
If this form relates to the If this form relates to the
registration of a class of registration of a class of
securities pursuant to securities pursuant to
Section 12(b) of the Exchange Act Section 12(g) of the Exchange Act
and is effective pursuant to and is effective pursuant to
General Instruction A.(c), please General Instruction A.(d), please
check the following box. [ ] check the following box. [X]
Securities Act registration statement file number to which
this form relates: 333-59557
------------------
(If applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Names of Each Exchange on Which
to be so Registered Each Class is to be Registered
- ------------------------------------- ------------------------------------
None Not Applicable
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, par value $.01 per share
- --------------------------------------------------------------------------------
(Title of Class)
<PAGE> 2
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
A description of the Registrant's Common Stock, par value $.01 per share,
being registered hereby is contained in the Registrant's Registration Statement
on Form S-4, as amended (Registration No. 333-59557) (the "Registration
Statement"), initially filed with the Securities and Exchange Commission on July
22, 1998, under the caption "Description of CPHI Capital Stock" and is
incorporated herein by reference.
ITEM 2. EXHIBITS.
Each of the following exhibits to this registration statement has been
filed as an exhibit to the Registration Statement (as defined above) and is
incorporated herein by reference:
<TABLE>
<CAPTION>
Exhibit
Number Description
- ------ -----------
<S> <C>
3.1 Certificate of Incorporation of the Registrant.
3.2 Bylaws of the Registrant.
4.2 Specimen stock certificate representing shares of Common Stock of
the Registrant.
</TABLE>
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized.
CELL PATHWAYS HOLDINGS, INC.
Date: September 11, 1998 By: /s/ RICHARD H. TROY
---------------------- ----------------------
Richard H. Troy
Senior Vice President of Corporate
Development, General Counsel and Secretary
